Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pharmaust Limited ( (AU:NUZ) ) has issued an announcement.
Neurizon Therapeutics Limited has announced a proposed issue of 750,000 ordinary fully paid securities, with the issuance date set for April 1, 2026. This move is part of the company’s strategy to raise capital, potentially impacting its market positioning and providing new opportunities for stakeholders.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.56 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Neurizon Therapeutics Limited operates in the pharmaceutical industry, focusing on the development and commercialization of therapeutic solutions. The company is engaged in issuing securities as part of its financial operations.
Average Trading Volume: 575,615
Technical Sentiment Signal: Hold
Current Market Cap: A$82.86M
For an in-depth examination of NUZ stock, go to TipRanks’ Overview page.